Susan G. Komen knows that even one more day without a cure for metastatic breast cancer is one day too many when lives are at stake. MBC is the most advanced stage of the disease. Though there are treatments to extend life, there is no cure. That’s why this year, Komen is going one step further to raise an extra $1 million to fund the first ever MBC Excellence in Research Award. Here today to tell us about this $1 Million Challenge and some of the promising new research the grant could fund is Dr. Kim Sabelko, Komen VP of Scientific Strategy and Programs.
